Replimune Group Inc (NASDAQ: REPL) on Friday, soared 4.00% from the previous trading day, before settling in for the closing price of $12.01. Within the past 52 weeks, REPL’s price has moved between $4.92 and $17.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 11.58%. With a float of $61.23 million, this company’s outstanding shares have now reached $68.39 million.
Considering the fact that the conglomerate employs 331 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 48.27%, operating margin of -5729.32%, and the pretax margin is -5260.12%.
Replimune Group Inc (REPL) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Replimune Group Inc is 18.53%, while institutional ownership is 81.28%. The most recent insider transaction that took place on Dec 16 ’24, was worth 124,200. In this transaction Chief Executive Officer of this company sold 10,000 shares at a rate of $12.42, taking the stock ownership to the 202,014 shares. Before that another transaction happened on Dec 16 ’24, when Company’s Chief Strategy Officer proposed sale 15,000 for $12.57, making the entire transaction worth $188,550.
Replimune Group Inc (REPL) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.58% per share during the next fiscal year.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Replimune Group Inc (REPL) is currently performing well based on its current performance indicators. A quick ratio of 10.11 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.12, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -2.61 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
Compared to the last year’s volume of 1.05 million, its volume of 1.25 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 41.61%. Additionally, its Average True Range was 0.86.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 43.27%, which indicates a significant decrease from 52.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.31% in the past 14 days, which was lower than the 73.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.20, while its 200-day Moving Average is $9.59. Nevertheless, the first resistance level for the watch stands at $13.21 in the near term. At $13.93, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.82. If the price goes on to break the first support level at $11.60, it is likely to go to the next support level at $10.71. Now, if the price goes above the second support level, the third support stands at $9.99.
Replimune Group Inc (NASDAQ: REPL) Key Stats
Market capitalization of the company is 978.61 million based on 68,417K outstanding shares. Right now, sales total 0 K and income totals -215,790 K. The company made 0 K in profit during its latest quarter, and -53,060 K in sales during its previous quarter.
